To study sugar lowering and cholesterol lowering effects of T. Saroglitazar in patients with abnormal Sugar and Cholesterol
Not Applicable
- Conditions
- Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
- Registration Number
- CTRI/2022/10/046795
- Lead Sponsor
- maulana azad medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with diabetic dyslipidemia with fasting triglycerides > 200-400 who are being treated with any of non insulin secretogogues( alpha glucose daze inhibitors, biguanides, SGLT-2 inhibitors) and low dose statin for at least 3 months.
Exclusion Criteria
patients on insulin, glitazar, glitazone, insulin secretogagues (sulfonylureas)
history of Thyroid disease, cardiac illness, liver disease (s.bilirubin > 2 times Upper normal limits), renal dysfunction(s.creatinine > 1.2mg/dL)
comorbid serious illness like tuberculosis, malignancy, HIV.
Pregnant and nursing mother
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method